Predictive Oncology Inc. (NASDAQ: POAI) Uses Smart Tumor Profiling Platform with AI to Bring Value to Pharmaceutical, Biotech Industries

September 19, 2019 11:06:42
  • POAI’s artificial intelligence (AI)-driven tumor profiling platform brings precision medicine tools to clinicians and researchers to improve cancer outcomes
  • The company holds a critical strategic advantage over mammoth competitors, attracting investor attention
  • POAI is committed to providing sophisticated tools to help select current therapies more precisely and develop new targeted therapies

Predictive Oncology Inc. (NASDAQ: POAI) is working with the pharmaceutical and biotech industries to offer an AI-driven tumor profiling platform that clinicians and researchers can use to improve outcomes for cancer patients of today and tomorrow. POAI has built a distinctly valuable asset in its existing base of drug-response outcome evidence; this data has the potential to revolutionize the way cancer is treated (http://nnw.fm/3mDNw).

Though seeming like David in the face of Goliath-sized competition, POAI holds a critical strategic advantage over such mammoth companies as Foundation Medicine and Tempus; while these competitors must wait at least five years to find out if the patient survived treatment before they can show value from their…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://nnw.fm/POAI

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com